MTXMinerals Technologies Inc.
Is the price fair?
Neither cheap nor expensive: growth expectations in line with delivery and in its normal P/E range.
Priced for ~6% a year FCF growth. Moderate growth expectations are priced in.
In its normal range: P/E 13.4 vs a 15.2 median over 36 quarters (−12% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What MTX's price assumes
Today's price asks for 5.9% free cash flow growth a year; over the last three years Minerals Technologies Inc. delivered 24%, less than the record.
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 4.9%
Free cash flow yield · Specialty Chemicals median 4.7%
- Growth the price implies
- +5.9%
Growth the price implies · The price pays for +5.9% free cash flow growth a year for a decade; the business has delivered +24% a year over the last three.
- Price / book
- 1.58
Price / book · today's price, trailing year to Jul 5, 2026
Details›
- Price / booktoday's price, trailing year to Jul 5, 2026
- 1.58
- EV / EBIToperating margin −1.3%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jul 5, 2026
- 1.43
- Free cash flow, trailing twelve months
- $120M
- Market capitalisation
- $2.44B
- 3-year revenue growth
- 0.00%
- 3-year free cash flow growth
- +24%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #25 of 33 by RyuScore